Richard B. Lanman

17.0k citations

193 papers · 8.0k indexed · 4 hit papers · h-index 47

Cancer Research top 0.2%
Pulmonary and Respiratory Medicine top 0.5%
Oncology top 0.5%
Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 0.5%

Co-authors: Rebecca J. Nagy Kimberly C. Banks Giulia C. Kennedy Lyssa Friedman Victoria M. Raymond Darya Chudova Justin I. Odegaard Juan Rosaí
Topics: Cancer Genomics and Diagnostics (145 papers)Lung Cancer Treatments and Mutations (87 papers)Genetic factors in colorectal cancer (61 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: New England Journal of Medicine Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Canada South Korea

In The Last Decade

Richard B. Lanman

181 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology

2012 791 citations Darya Chudova, Richard B. Lanman et al. profile →
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

2015 470 citations Richard B. Lanman, Stefanie Mortimer et al. profile →
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer

2019 408 citations Natasha B. Leighl, Ray D. Page et al. Clinical Cancer Research profile →
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

2018 271 citations Oliver A. Zill, Kimberly C. Banks et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Richard B. Lanman

Since Specialization

Citations

This map shows the geographic impact of Richard B. Lanman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Lanman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Lanman more than expected).

Fields of papers citing papers by Richard B. Lanman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Lanman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Lanman. The network helps show where Richard B. Lanman may publish in the future.

Co-authorship network of co-authors of Richard B. Lanman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Lanman. A scholar is included among the top collaborators of Richard B. Lanman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Lanman. Richard B. Lanman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancerbreakdown → 2019 ·Clinical Cancer Research ·Natasha B. Leighl,Ray D. Page,Victoria M. Raymond,Davey B. Daniel,Stephen G. Divers,Karen L. Reckamp,Miguel A. Villalona‐Calero,Daniel Dix,Justin I. Odegaard,Richard B. Lanman,Vassiliki A. Papadimitrakopoulou	408
2	Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma 2019 ·Clinical Cancer Research ·Steven B. Maron,Leah M. Chase,Samantha Lomnicki,Sara Kochanny,Kelly L. Moore,Smita S. Joshi,(unknown),(unknown),Lesli A. Kiedrowski,Rebecca J. Nagy,Richard B. Lanman,Seung Tae Kim,Jeeyun Lee,Daniel V.T. Catenacci	147
3	Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations 2019 ·Clinical Cancer Research ·Siddhartha Devarakonda,Sumithra Sankararaman,Brett H. Herzog,Kathryn A. Gold,Saiama N. Waqar,Jeffrey P. Ward,Victoria M. Raymond,Richard B. Lanman,Aadel A. Chaudhuri,Taofeek K. Owonikoko,Bob T. Li,John T. Poirier,Charles M. Rudin,Ramaswamy Govindan,Daniel Morgensztern	41
4	Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations 2019 ·Clinical Cancer Research ·Thereasa A. Rich,Karen L. Reckamp,Young Kwang Chae,Robert C. Doebele,Wade T. Iams,Michael S. Oh,Victoria M. Raymond,Richard B. Lanman,Jonathan W. Riess,Thomas E. Stinchcombe,Vivek Subbiah,David R. Trevarthen,Stephen R. Fairclough,Jennifer Yen,Oliver Gautschi	68
5	Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer 2019 ·Clinical Cancer Research ·(unknown),Kenneth R. Hess,Filip Jankú,Nora Sánchez,Kenna Shaw,Cathy Eng,Senthilkumar Damodaran,Milind Javle,Ahmed O. Kaseb,David S. Hong,Vivek Subbiah,Siqing Fu,David R. Fogelman,Victoria M. Raymond,Richard B. Lanman,Funda Meric‐Bernstam	40
6	Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity 2019 ·Clinical Cancer Research ·Ibiayi Dagogo‐Jack,Marguerite Rooney,W. Marston Linehan,Rebecca J. Nagy,Beow Y. Yeap,Harper Hubbeling,Emily Chin,Jennifer Ackil,Anna F. Farago,Aaron N. Hata,Jochen K. Lennerz,Justin F. Gainor,Richard B. Lanman,Alice T. Shaw	112
7	Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics 2019 ·Molecular Cancer Therapeutics ·In Sil Choi,Shumei Kato,Paul T. Fanta,Lawrence Leichman,Ryosuke Okamura,Victoria M. Raymond,Richard B. Lanman,Scott M. Lippman,Razelle Kurzrock	21
8	Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer 2019 ·Cancer ·Guru Sonpavde,Neeraj Agarwal,Gregory R. Pond,Rebecca J. Nagy,Roberto Nussenzveig,Andrew W. Hahn,Oliver Sartor,Theodore Stewart Gourdin,Lakshminarayanan Nandagopal,Elisa M. Ledet,Gurudatta Naik,Andrew J. Armstrong,Jue Wang,Mehmet Asım Bilen,Shilpa Gupta,Petros Grivas,Sumanta K. Pal,Richard B. Lanman,AmirAli Talasaz,Michelle M. Lilly	41
9	Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies 2018 ·Clinical Cancer Research ·Justin I. Odegaard,John J. Vincent,Stefanie Mortimer,James V. Vowles,Bryan C. Ulrich,Kimberly C. Banks,Stephen R. Fairclough,Oliver A. Zill,Marcin Sikora,Reza Bayat Mokhtari,Diana Abdueva,Rebecca J. Nagy,Christine E. Lee,Lesli A. Kiedrowski,Cloud P. Paweletz,Helmy Eltoukhy,Richard B. Lanman,Darya Chudova,AmirAli Talasaz	283
10	Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma 2018 ·Cancer Discovery ·Steven B. Maron,Lindsay Alpert,Heewon Kwak,Samantha Lomnicki,Leah M. Chase,David Xu,Emily O’Day,Rebecca J. Nagy,Richard B. Lanman,Franco Cecchi,Todd Hembrough,Alexa B. Schrock,John Hart,Shu‐Yuan Xiao,Namrata Setia,Daniel V.T. Catenacci	79
11	Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer 2018 ·Clinical Cancer Research ·Caroline E. McCoach,Collin M. Blakely,Kimberly C. Banks,Benjamin Levy,(unknown),Victoria M. Raymond,Anh T. Le,Christine E. Lee,Joseph A. Diaz,Saiama N. Waqar,W. Thomas Purcell,Dara L. Aisner,(unknown),Richard B. Lanman,Alice T. Shaw,Robert C. Doebele	114
12	The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patientsbreakdown → 2018 ·Clinical Cancer Research ·Oliver A. Zill,Kimberly C. Banks,Stephen R. Fairclough,Stefanie Mortimer,James V. Vowles,Reza Bayat Mokhtari,David R. Gandara,Philip C. Mack,Justin I. Odegaard,Rebecca J. Nagy,Arthur M. Baca,Helmy Eltoukhy,Darya Chudova,Richard B. Lanman,AmirAli Talasaz	271
13	Anaplastic Lymphoma Kinase Mutation ( ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib 2018 ·Clinical Cancer Research ·Benedito A. Carneiro,Sahithi Pamarthy,Ami N. Shah,Vinay Sagar,Kenji Unno,Huiying Han,Ximing J. Yang,(unknown),Rebecca J. Nagy,Richard B. Lanman,Timothy M. Kuzel,Jeffrey S. Ross,Laurie M. Gay,Julia A. Elvin,Siraj M. Ali,Massimo Cristofanilli,Young Kwang Chae,Francis J. Giles,Sarki A. Abdulkadir	34
14	Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary 2017 ·Cancer Research ·Shumei Kato,Nithya Krishnamurthy,Kimberly C. Banks,Pradip De,Kirstin Williams,Casey Williams,Brian Leyland‐Jones,Scott M. Lippman,Richard B. Lanman,Razelle Kurzrock	90
15	Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer 2017 ·Cancer Discovery ·John H. Strickler,Jonathan M. Loree,Leanne G. Ahronian,Aparna R. Parikh,Donna Niedzwiecki,Allan Andresson Lima Pereira,Matthew McKinney,W. Michael Korn,Chloé E. Atreya,Kimberly C. Banks,Rebecca J. Nagy,Funda Meric‐Bernstam,Richard B. Lanman,AmirAli Talasaz,Igor F. Tsigelny,Ryan B. Corcoran,Scott Kopetz	196
16	Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma 2017 ·Clinical Cancer Research ·Maria Schwaederlé,Sandip Pravin Patel,Hatim Husain,Megumi Ikeda,Richard B. Lanman,Kimberly C. Banks,AmirAli Talasaz,Lyudmila Bazhenova,Razelle Kurzrock	118
17	Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients 2017 ·Clinical Cancer Research ·Yuebi Hu,Ryan S. Alden,Justin I. Odegaard,Stephen R. Fairclough,(unknown),Jennifer Heng,Nora Feeney,Rebecca J. Nagy,(unknown),Bryan C. Ulrich,(unknown),Richard B. Lanman,Judy E. Garber,Cloud P. Paweletz,Geoffrey R. Oxnard	63
18	PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K α Inhibitors 2017 ·Clinical Cancer Research ·Sarah Croessmann,Jonathan H. Sheehan,Kyung‐min Lee,Gregory Sliwoski,Jie He,Rebecca J. Nagy,David R. Riddle,Ingrid A. Mayer,Justin M. Balko,Richard B. Lanman,Vincent A. Miller,Lewis C. Cantley,Jens Meiler,Carlos L. Arteaga	27
19	Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing 2017 ·Cancer Research ·Maria Schwaederlé,Ranajoy Chattopadhyay,Shumei Kato,Paul T. Fanta,Kimberly C. Banks,In Sil Choi,David Piccioni,Sadakatsu Ikeda,AmirAli Talasaz,Richard B. Lanman,Lyudmila Bazhenova,Razelle Kurzrock	89
20	Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer 2016 ·Oncotarget ·Victoria Villaflor,(unknown),Rebecca J. Nagy,Kimberly C. Banks,Richard B. Lanman,AmirAli Talasaz,Ravi Salgia	48

About Richard B. Lanman

Richard B. Lanman is a scholar working on Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 193 papers that have together received 8.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (145 papers), Lung Cancer Treatments and Mutations (87 papers) and Genetic factors in colorectal cancer (61 papers). The work is most often cited by research in Cancer Research (4.0k citations), Oncology (3.2k citations) and Pulmonary and Respiratory Medicine (3.7k citations). Richard B. Lanman has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Rebecca J. Nagy, Kimberly C. Banks, Giulia C. Kennedy, Lyssa Friedman, Victoria M. Raymond, Darya Chudova, Justin I. Odegaard, Juan Rosaí, Virginia A. LiVolsi and AmirAli Talasaz. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact